Johnson & Johnson

NYSE : JNJ
$255.56−0.66%Oct 16 close

Financials

Original filing

Consolidated Balance Sheets

USD · reported units.

Consolidated Balance Sheets, filing 0000200406-26-000153. USD · reported units.
Reported line itemJun 28, 2026 (current)Dec 28, 2025
Statement of Financial Position [Abstract]
Assets
Current assets:
Cash and cash equivalents (Note 4)
Marketable securities
Accounts receivable, trade, less allowances $171 (2025, $183)
Inventories (Note 2)
Prepaid expenses and other
Total current assets
Property, plant and equipment at cost
Less: accumulated depreciation
Property, plant and equipment, net
Intangible assets, net (Note 3)
Goodwill (Note 3)
Deferred taxes on income (Note 5)
Other assets
Total assets
Liabilities and shareholders’ equity
Current liabilities:
Loans and notes payable
Accounts payable
Accrued liabilities
Accrued rebates, returns and promotions
Accrued compensation and employee related obligations
Accrued taxes on income (Note 5)
Total current liabilities
Long-term debt (Note 4)
Deferred taxes on income (Note 5)
Employee related obligations (Note 6)
Long-term taxes payable (Note 5)
Other liabilities
Total liabilities
Commitments and Contingencies (Note 11)——
Shareholders’ equity:
Common stock — par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)
Accumulated other comprehensive income (loss) (Note 7)
Retained earnings and Additional paid-in capital
Less: common stock held in treasury, at cost (711,615,000 and 711,904,000 shares)
Total shareholders’ equity
Total shareholders’ equity
Total liabilities and shareholders’ equity
35 line items · 2 reported periodsOriginal filing order · parentheses indicate negative amounts

Each column reflects this filing’s presentation. Original line items and period dates are preserved.

Arithmetic validation is incomplete for this statement. Source values remain individually inspectable.